
VETSTEM LLC proudly announces receipt of registration certificate for innovative animal anesthesia drug VEZOTIL from Rosselkhoznadzor.
This landmark event is the result of many years of work by a team of scientists and veterinary specialists who developed a safe and effective drug for general anesthesia of cats and dogs.
Key achievements:
- Successful completion of all stages of preclinical and clinical studies
- Confirmation of high efficacy and safety of the drug
- Compliance with all requirements of Russian legislation
- Permission for industrial production obtained
VEZOTIL contains tiletamine hydrochloride and zolazepam hydrochloride in equal proportions, providing stable and predictable anesthesia for various veterinary procedures.
Advantages of the new drug:
VEZOTIL differs from analogues by high application safety and anesthesia controllability. Effect onset time is only 3-5 minutes, which significantly reduces preparation time for surgical interventions.
It is particularly important to note that the drug provides stable cardiovascular and respiratory function during anesthesia, which is critical for patient safety.
Implementation plans:
In the coming months, VEZOTIL will be available to veterinary clinics throughout Russia. The company plans to conduct a series of training seminars for veterinarians on proper drug use.